Early Access Program With Inolimomab in Steroid-refractory Acute Graft Versus Host Disease

NCT05047328 · clinicaltrials.gov ↗

AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Steroid Resistant Acute Graft Versus Host Disease

Interventions

BIOLOGICAL: inolimomab

Sponsor

ElsaLys Biotech